← FDA DRUG APPROVALS

FDA NDA · NDA018104

HYLOREL

Sponsor: PHARMACIA AND UPJOHN

APPLICATION
NDA018104
TYPE
NDA
ORIGINAL APPROVAL
1982-12-29
LATEST ACTION
1990-08-01
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

HYLORELDiscontinued
GUANADREL SULFATE 10MG · TABLET · ORAL
HYLORELDiscontinued
GUANADREL SULFATE 25MG · TABLET · ORAL

Approval history

1990-08-01Labeling · Supplement 6AP
1990-08-01Labeling · Supplement 7AP
1986-10-07Manufacturing (CMC) · Supplement 5 · standardAP
1985-08-20Labeling · Supplement 3AP
1985-08-20Labeling · Supplement 4AP
1983-09-13Manufacturing (CMC) · Supplement 2 · standardAP
1983-04-01Labeling · Supplement 1AP
1982-12-29Type 1 - New Molecular Entity · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →